Brief: Ovid Therapeutics Inc - Receives Nasdaq Notice For Minimum Bid Price Non-Compliance
13/02/2025 22:25
Ovid Therapeutics Inc OVID.O :
* OVID THERAPEUTICS INC - RECEIVES NASDAQ NOTICE FOR MINIMUM
BID
PRICE NON-COMPLIANCE
Source text: ID:n0001193125-25-026192
Further company coverage: OVID.O
Recent news on Ovid Therapeutics
See all newsOvid Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Ovid Therapeutics Q2 revenue beats estimates
Brief: Ovid Therapeutics Q2 EPS USD -0.08
Ovid Therapeutics Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Ovid Therapeutics Appoints Leading Physician-Scientist And Biotech Innovator Anna Greka, M.D., Ph.D., To Board Of Directors